4-hydroxy-2,3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis (Review)

International Journal of Molecular Medicine

Volumn 4, Issue 4, 1999, Pages 425-432

  Parola, Maurizio ^a   Robino, Gaia ^a   Dianzani, Mario Umberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

4 hydroxyalkenals; 4 hydroxynonenal; Hepatic stellate cells; Liver fibrosis; Oxidativev stress

Indexed keywords

4 HYDROXY 2,3 ALKENAL DERIVATIVE; CHEMOKINE; CYTOKINE; GROWTH FACTOR; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG; ALKENE; UNSATURATED FATTY ACID;

ARTICLE; CHRONIC LIVER DISEASE; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; HUMAN CELL; IN VIVO STUDY; ITO CELL; KUPFFER CELL; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; LIVER SINUSOID; OXIDATIVE STRESS; PRIMARY CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STELLATE CELL; LIVER CIRRHOSIS; METABOLISM; OXIDATION REDUCTION REACTION; REVIEW;

ALKENES; FATTY ACIDS, UNSATURATED; HUMANS; LIVER CIRRHOSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 0033209610     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.4.4.425     Document Type: Article

References (81)

1. Halliwell B: Free radicals, antioxidants and human diseases: curiosity, cause or consequences? Lancet 344: 721-724, 1994.
2. Griendling KK and Alexander RW: Oxidative stress and cardiovascular disease. Circulation 96: 3264-3265, 1997.
3. Guyton KZ and Kensier TW: Oxidative mechanisms in carcinogenesis. Br Med Bull 49: 523-544, 1993.
4. Breen AP and Murphy JA: Reaction of oxyl radicals with DNA. Free Radie Biol Med 18: 1033-1077, 1995.
5. Quinlan TR, Marsh JP, Janssen YM, Borm PA and Mossman BT: Oxygen radicals and asbestos-mediated disease. Environ Health Perspect 102 (Suppl. 10): 107-110, 1994.
6. Louie S, Halliwell B and Cross CE: Adult respiratory distress syndrome: a radical perspective. Adv Pharmacol 38: 457-490, 1997.
7. Markesbery WR: Oxidative stress hypothesis in Alzheimer's disease. Free Radie Biol Med 23: 134-147, 1997.
8. Keller JN and Mattson MP: Role of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 9: 105-116, 1998.
9. Berlett BS and Stadtman ER: Protein oxidation in aging, disease and oxidative stress. J Biol Chem 272: 20313-20316, 1997.
10. Poli G and Parola M: Oxidative damage and fibrogenesis. Free Radie Biol Med 22: 287-305, 1997.
11. Britton RS and Bacon BR: Role of free radicals in liver diseases. Hepatogastroenterology 41: 343-348, 1994.
12. Tsukamoto H, Rippe R, Niemela O and Lin M: Role of oxidative stress in the activation of Kupffer and Ito cell. J Gastroenterol Hepatol 10: S50-S53, 1995.
13. Pietrangelo A: Metals, oxidative damage and fibrogenesis. Semin Liver Dis 16: 13-30, 1996.
14. Crawford D, Zbinden I, Amstad P and Cerruti P: Oxidant stress induces the protooncogenes c-fos and c-myc in mouse epidermal cells. Oncogene 3: 27-32, 1988.
15. Shibanuma M, Kuroki T and Nose K: Induction of DNA replication and expression of protooncogenes c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene 3: 17-21, 1988.
16. Abate C, Patel L, Rauscher FJ III and Curran T: Redox regulation of Fos and Jun DNA binding activity in vitro. Science 249: 1157-1161, 1990.
17. Schreck R, Rieber P and Bauerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-KB transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
18. Lo YYC, Wong JMS and Cruz TF: Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 271: 15703-15707, 1996.
19. Chakraborti S and Chakraborti T: Oxidant-mediated activation of mitogen-activated protein kinases and nuclear trancription factors in cardiovascular system: a brief overview. Cell Signal 10: 675-683, 1998.
20. Krejsa CM and Schieve GL: Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases. Environ Health Perspect 106: 1179-1184, 1998.
21. Halliwell B and Gutteridge JMC: Free Radicals in Biology and Medicine. 2nd edition. Clarendon Press, Oxford, 1989.
22. Arnaiz SL, Llesuy S, Cutrin JC and Boveris A: Oxidative stress by acute acetaminophen administration in mouse liver. Free Radie Biol Med 19: 303-310, 1995.
23. Slater TF: Free radical mechanisms in tissue injury. Biochem J 22: 1-15, 1982.
24. Esterbauer H, Schaur RJ and Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radie Biol Med 11: 81-128, 1991.
25. Benedetti A, Comporti M and Esterbauer H: Identification of 4- hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 620:281-296, 1980.
26. Dianzani MU: Biochemical effects of saturated and unsaturated aldehydes. In: Free Radicals, Lipid Peroxidation and Cancer. McBrien DHC and Slater TF (eds). Academic Press, London, ppl29-158, 1982.
27. Comporti M: Lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 53: 599-623, 1985.
28. Dianzani MU: 4-hydroxynonenal and cell signaling. Free Radie Res 28: 553-560, 1998.
29. Dianzani MU, Barrera G and Parola M: 4-hydroxy-2, 3-nonenal as a signal for cell function and differentiation. Acta Biochim Pol 46: 61-75, 1999.
30. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835, 1993.
31. Schuppan D: Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 10: 1-10, 1990.
32. Bissei M: Lipocyte activation and hepatic fibrosis. Gastroenterology 102: 1803-1805, 1992.
33. Pinzani M: Hepatic stellate (Ito) cells: expanding roles for a liver-specific pericyte. J Hepatol 22: 700-706, 1995.
34. Pinzani M, Marra F and Carloni V: Signal transduction in hepatic stellate cells. Liver 18: 2-13, 1998.
35. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, Opolon P, Holstege A, Poynard T and Bedossa P: In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 50:401-406, 1997.
36. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T and Bedossa P: In situ detection of lipid peroxidation byproducts in chronic liver diseases. Hepatology 26: 135-142, 1997.
37. Ohira M, Ohtake M, Matsumoto A, Saito H, Ikuta K, Fujimoto Y, Ono M, Toyokumi S and Kohgo Y: Immunohistochemical detection of 4-hydroxy-2-nonenal-modified protein adducts in human alcoholic liver disease. Alcohol Clin Exp Res 22: 145-149, 1998.
38. Aleynik SI, Leo MA, Aleynik MK and Lieber CS: Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin Exp Res 22: 192-196, 1998.
39. Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli G and Dianzani MU: Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver injury and cirrhosis. Hepatology 16: 1014-1021, 1992.
40. Bedossa P, Houghlum K, Trautwein C, Holstege A and Chojkier M: Stimulation of collagen al(I) gene expression is associated with lipid peroxidation in hepatocellular injury. A link to tissue fibrosis? Hepatology 19: 1262-1271, 1994.
41. Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G and Tsukamoto H: Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrosis. Hepatology 16:448-453, 1992.
42. Niemela O, Parkkila S, Yla-Herttuala S, Villanueva J, Ruebner B and Halsted CH: Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcoholinduced liver disease. Hepatology 22: 1208-1214, 1995.
43. Niemela O, Parkkila S, Pasanen M, Iimur Y, Bradford B and Thurman RG: Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. Alcohol Clin Exp Res 22: 2118-2124, 1998.
44. Li CJ, Nanji AA, Siakotos AN and Lin RC: Acetaldehydemodified and 4-hydroxynonenal-modified proteins in the liver of rats with alcoholic liver disease. Hepatology 26: 650-657, 1997.
45. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S and Brittenham G: Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96: 620-630, 1995.
46. Parola M, Leonarduzzi G, Robino G, Albano E, Poli G and Dianzani MU: On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radie Biol Med 20: 351-359, 1996.
47. Houghlum K, Filip M, Witztum JL and Chojkier M: Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 86: 1991-1998, 1990.
48. Alin P, Danielson UH and Mannervik B: 4-hydroxy-2-enals are substrates for glutathione transferase. FEBS Lett 179: 267-270, 1985.
49. Ketterer B: Glutathione S-transferase and prevention of cellular free radical damage. Free Radie Res 28: 647-658, 1998.
50. Canuto RA, Ferro M, Muzio G, Bassi AM, Leonarduzzi G, Maggiora M, Adamo D, Poli G and Lindhal R: Role of aldehyde metabolizing enzyme in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis 15: 1359-1364, 1994.
51. Hartley DP, Ruth JA and Petersen DR: The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase and glutathione-S-transferase. Arch Biochem Biophys 316: 197-205, 1995.
52. Siems WG, Zollner H, Grune T and Esterbauer H: Metabolie fate of 4-hydroxynonenal in hepatocytes: 1, 4-dihydroxynonene is not the main product. J Lipid Res 38: 612-622, 1997.
53. Srivastava S, Chandra A, Bhatnagar A, Srivastava SS and Ansari NH: Lipid peroxidation product 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem Biophys Res Commun 217: 741-746, 1995.
54. Ferro M, Marinari UM, Poli G, Dianzani MU, Fauler G, Zollner H and Esterbauer H: Metabolism of 4-hydroxynonenal by the rat hepatoma cell line with MHjC, . Cell Biochem Funct 6: 245-250, 1988.
55. Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogl S, Dargel R and Poli G: The lipid peroxidation end product 4-hydroxy-2, 3-nonenal up-regulates transforming growth factor ßl expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11:851-857, 1997.
56. Parola M, Robino G, Marra F, Pinzani M, Bellomo G, Leonarduzzi G, Chiarugi P, Camandola S, Poli G, Gentilini P and Dianzani MU: HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 102: 1942-1950, 1998.
57. Uchida K and Stadtman ER: Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sei USA 89: 4544-4548, 1992.
58. Uchida K, Szweda LI, Chae H and Stadtman ER: Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sei USA 90: 8742-8746, 1993.
59. Uchida K and Stadtman ER: Quantitation of 4-hydroxynonenal protein adducts. Methods Enzymol 233: 371-380, 1994.
60. Uchida K, Tokoyuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H and Stadtman ER: Michael addition-type 4-hydroxy-2, 3- nonenal adducts in modified low density lipoproteins: markers for atherosclerosis. Biochemistry 33: 12487-12494, 1994.
61. Nadkarni DV and Sayre LM: Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem Res Toxicol 8: 284-291, 1995.
62. Friguet B, Stadtman ER and Szweda LI: Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem 269: 21639-21643, 1994.
63. Waeg G, Dimsity G and Esterbauer H: Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radie Res 25: 149-159, 1996.
64. Blanc EM, Kelly JF, Mark RJ, Waeg G and Mattson MP: 4- hydroxynonenal, an aldehydic product of lipid peroxidation, inpairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possibile action on G alpha (q/11). J Neurochem 69: 570-580, 1997.
65. Parola M, Muraca R, Dianzani I, Barrera G, Leonarduzzi G, Bendinelli P, Piccoletti R and Poli G: Vitamin E dietary supplementation inhibits transforming growth factor ßl gene expression in rat liver. FEBS Lett 308: 267-270, 1992.
66. Curzio M, Esterbauer H, Di Mauro C, Cecchini G and Dianzani MU: Chemotactic activity of the lipid peroxidation products 4-hydroxynonenal and homologous aldehydes. Biol Chem Hoppe Seyler 367: 321-329, 1986.
67. Curzio M, Esterbauer H, Di Mauro C and Dianzani MU: Influence of the lipid peroxidation product 4-hydroxynonenal on human neutrophil migration. Int J Tissue React 6: 13-18, 1990.
68. Schaur RJ, Dussing G, Kink E, Schauenstein E, Posh K, Kukovetz E and Egger G: The lipid peroxidation product 4- hydroxynonenal is formed and is able to attract rat neutrophils in vivo. Free Radie Res 20: 365-373, 1994.
69. Müller K, Hardwick SJ, Marchant CE, Law NS, Waeg G, Esterbauer H, Carpenter KLH and Mitchinson MJ: Cytotoxic and chemotactic potencies of several aldehydic components of oxidized low density lipoprotein for human monocytemacrophages. FEBS Lett 388: 165-168, 1996.
70. Glasgow WC, Harris TM and Brash AR: A short chain aldehyde is a major lipoxygenase product in arachidonic acid-stimulated porcine leukocytes. J Biol Chem 261: 200-204, 1986.
71. Rossi MA, Di Mauro C, Esterbauer H, Fidale F and Dianzani MU: Activation of phosphoinositide-specific phospholipase C of rat neutrophils by the chemotactic aldehydes 4-hydroxy-2, 3-transnonenal and 4-hydroxy-2, 3-trans-octenal. Cell Biochem Funct 12: 275-280, 1994.
72. Marra F, De Franco R, Grappone C, Parola M, Milani S, Leonarduzzi G, Pastacaldi S, Wenzel UO, Pinzani MU, Dianzani MU, Laffi G and Gentilini P: Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury; modulation by vitamin E pretreatment. J Investig Med 47: 66-75, 1999.
73. Pietrangelo A, Gualdi R, Casalgrandi G, Montosi G and Ventura E: Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest 95: 1824-1831, 1995.
74. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini P and Dianzani MU: Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen a 1(1) gene expression in human fat-storing cells. Biochem Biophys Res Commun 194: 1044-1050, 1993.
75. Casini A, Ceni E, Salzano R, Biondi P, Parola M, Galli A, Foschi M, Caligiuri A, Pinzani M and Surrenti C: Neutrophil - derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 25: 361-367, 1997.
76. Parola M, Pinzani M, Casini A, Leonarduzzi G, Marra F, Caligiuri A, Ceni E, Biondi P, Poli G and Dianzani MU: Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2, 3-nonenal and other 4-hydroxy-2, 3-alkenals is related to their molecular structure. Biochem Biophys Res Commun 222: 261-264, 1996.
77. Mäher JJ and Neuschwander-Tetri BA: Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis. Hepatology 26: 618-623, 1997.
78. Lee FK, Hagler J, Chen ZJ and Maniatis T: Activation of the IKBCX kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88: 213-222, 1997.
79. Uchida K, Shiraichi M, Naito Y, Torii Y, Nakamura Y and Osawa T: Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274: 2234-2242, 1999.
80. Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH and Seyer JM: Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I gene expression. Biochem J 304: 817-824, 1994.
81. Chen A and Davis BH: UV irradiation activates JNK and increases alpha (I) collagen gene expression in rat hepatic stellate cells. J Biol Chem 274: 158-164